U.S. Markets closed

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.77+0.22 (+3.36%)
At close: 4:00PM EDT

6.79 +0.02 (0.30%)
After hours: 6:35PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.11
52-Week Change 326.94%
S&P500 52-Week Change 3N/A
52 Week High 38.05
52 Week Low 31.48
50-Day Moving Average 35.29
200-Day Moving Average 34.19

Share Statistics

Avg Vol (3 month) 31.42M
Avg Vol (10 day) 31.04M
Shares Outstanding 534.37M
Float 25.88M
% Held by Insiders 14.01%
% Held by Institutions 165.87%
Shares Short (Jul 14, 2020) 4574.08k
Short Ratio (Jul 14, 2020) 40.34
Short % of Float (Jul 14, 2020) 41.99%
Short % of Shares Outstanding (Jul 14, 2020) 41.67%
Shares Short (prior month Jun 14, 2020) 4886.56k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-45.74%
Return on Equity (ttm)-90.32%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -55.17M
Net Income Avi to Common (ttm)-55.07M
Diluted EPS (ttm)-1.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)38.38M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)14.84M
Total Debt/Equity (mrq)34.14
Current Ratio (mrq)12.84
Book Value Per Share (mrq)1.47

Cash Flow Statement

Operating Cash Flow (ttm)-47.71M
Levered Free Cash Flow (ttm)-11.74M